These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17963631)
41. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring. Podjarny E; Korzets Z; Bernheim J J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849 [TBL] [Abstract][Full Text] [Related]
42. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
43. [Does ambulatory determination of blood pressure allow the measurement of white coat effect?]. Valty J; Cohen A; Guyon P; Petit F; Sagnes JY Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1169-72. PubMed ID: 1482254 [TBL] [Abstract][Full Text] [Related]
44. Telemonitoring of 24-Hour Blood Pressure in Local Pharmacies and Blood Pressure Control in the Community: The Templar Project. Omboni S; Mancinelli A; Rizzi F; Parati G; Am J Hypertens; 2019 Jun; 32(7):629-639. PubMed ID: 30976783 [TBL] [Abstract][Full Text] [Related]
45. Determinants of the white-coat effect in normotensives and never-treated mild hypertensives. Tsai PS Clin Exp Hypertens; 2003 Oct; 25(7):443-54. PubMed ID: 14596368 [TBL] [Abstract][Full Text] [Related]
46. Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Stenehjem AE; Os I Blood Press; 2004; 13(4):214-24. PubMed ID: 15581335 [TBL] [Abstract][Full Text] [Related]
52. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension. Mulè G; Nardi E; Cottone S; Andronico G; Federico MR; Piazza G; Volpe V; Ferrara D; Cerasola G Am J Hypertens; 2003 Jun; 16(6):498-501. PubMed ID: 12799101 [TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of the white coat effect. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C Hypertension; 1997 Jun; 29(6):1218-24. PubMed ID: 9180621 [TBL] [Abstract][Full Text] [Related]
54. [Importance of ambulatory blood pressure monitoring in adolescent hypertension]. Páll D; Juhász M; Katona E; Lengyel S; Komonyi E; Fülesdi B; Paragh G Orv Hetil; 2009 Dec; 150(49):2211-7. PubMed ID: 19939781 [TBL] [Abstract][Full Text] [Related]
55. [Diagnosis of hypertension in general practice--are office pressure measurements sufficient?]. Dyrdal A; Lindbaek M Tidsskr Nor Laegeforen; 2003 Jan; 123(2):147-51. PubMed ID: 12607493 [No Abstract] [Full Text] [Related]
56. Twenty-Four-Hour Ambulatory Blood Pressure Monitoring. Pena-Hernandez C; Nugent K; Tuncel M J Prim Care Community Health; 2020; 11():2150132720940519. PubMed ID: 32646277 [TBL] [Abstract][Full Text] [Related]
57. [Syndrome of white coat hypertension in pregnant women]. Striuk RI; Bortnikova VN Kardiologiia; 2006; 46(11):44-7. PubMed ID: 17159881 [TBL] [Abstract][Full Text] [Related]
58. A population-based study of the white-coat blood pressure effect: positive correlation with plasma cortisol. Nyström F; Aardal E; Ohman KP Clin Exp Hypertens; 1998 Jan; 20(1):95-104. PubMed ID: 9507791 [TBL] [Abstract][Full Text] [Related]
59. Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring. Moore CR; Krakoff LR; Phillips RA Hypertension; 1997 May; 29(5):1109-13. PubMed ID: 9149674 [TBL] [Abstract][Full Text] [Related]
60. The prevalence of silent myocardial ischaemia in patients with white-coat hypertension. Nalbantgil I; Onder R; Nalbantgil S; Yilmaz H; Boydak B J Hum Hypertens; 1998 May; 12(5):337-41. PubMed ID: 9655656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]